Medicine

Scientists at EPFL’s Blue Brain Project have developed a groundbreaking computational model of the thalamic microcircuit in the mouse brain, offering new insights into the role this region plays in brain function and dysfunction.

EPFL scientists are developing a new approach that can help stem the tide of antibiotic resistance.

A team led by ETH Zurich chemical engineers Chih-Jen Shih and Andrew deMello have developed a rapid test system made of smart graphene paper. It only costs a few cents per test strip, is easy to use but is as accurate as lab measurements. The approach will impact more than just disease monitoring.

Increasingly dense cell clusters in growing tumours convert blood vessels into fibre-filled channels. This makes immune cells less effective, as findings by researchers from ETH Zurich and the University of Strasbourg suggest.

Cancer patients might one day benefit from being administered immune cells from healthy donors. But as things stand, receiving donor cells can cause severe or even fatal immune reactions. A researcher at ETH Zurich has now developed a technology that avoids these.

Since 2016, the Swiss Cancer Center Léman provides a space for scientists and clinicians from across the Lake Geneva region to pool their efforts, share insights and work together on innovative cancer treatments. The center, which has just renewed its leadership team, brings together the Universities of Geneva and Lausanne, the EPFL, and the two hospitals, CHUV and HUG.